Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzodiazepine SCHEMBL28099137 | 0.80 | GAA (0.38) | — | |
| Hydrochloric Acid SCHEMBL8523808 | 0.78 | DYRK1A (0.34) | KDM4EALDH1A1HPGD | |
| SCHEMBL9048951 | 0.78 | DYRK1A (0.34) | DRD4 | |
| Benzodiazepine SCHEMBL28097900 | 0.75 | CA12 (0.38) | — | |
| Benzodiazepine SCHEMBL28093843 | 0.73 | MAPT (0.38) | KDM4EALDH1A1HPGD | |
| Benzodiazepine SCHEMBL7160172 | 0.72 | GAA (0.44) | — | |
| Benzodiazepine SCHEMBL4700331 | 0.71 | GAA (0.43) | — | |
| Benzodiazepine SCHEMBL11484022 | 0.71 | GAA (0.43) | — | |
| Benzodiazepine SCHEMBL6618830 | 0.71 | GAA (0.43) | — | |
| Benzodiazepine SCHEMBL936208 | 0.71 | GAA (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2102201-A2 | SUBSTITUTED DIAZEPINE SULFONAMIDES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS | Merck & Co., Inc. (US) | 2009-09-23 | — | — | EP | disclosed |
| WO-2008073311-A2 | SUBSTITUTED DIAZEPINE SULFONAMIDES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS | MERCK & CO., INC. (US) | 2008-06-19 | — | — | WO | disclosed |